SECsense Logo

Cyclo Therapeutics, Inc. 8-K Report: Key Financial Updates & Stock Insights

$CYTHW
Form 8-K
Filed on: 2023-12-28
Source
Cyclo Therapeutics, Inc. 8-K Report: Key Financial Updates & Stock Insights

Based on the provided section of the financial report, here are the key pieces of information extracted:

  1. Entity Information:
  • Company Name: Cyclo Therapeutics, Inc.
  • CIK (Central Index Key): 0000922247
  • Address: 6714 NW 16th Street, Suite B, Gainesville, FL 32653
  • Phone Number: 386-418-8060
  • SEC Filing Type: 8-K
  1. Ticker Symbols:
  • Common Stock Ticker: CYTH (listed on NASDAQ)
  • Warrants Ticker: CYTHW (listed on NASDAQ)
  1. Filing Date: The report is dated December 26, 2023.
  2. Stock Classifications:
  • The report includes classifications for:
    • Common Stock
    • Warrants to Purchase Common Stock
  1. Filing Context:
  • There are specific contexts provided for the Common Stock and Warrants to Purchase Common Stock, indicating that the data is segmented and relates to different classes of stock.
  1. Reporting Period:
  • The reporting period for the information is also December 26, 2023, indicating that this is likely a specific event or update pertinent to that date.

Insights:

  • The presence of both common stock and warrants suggests that Cyclo Therapeutics, Inc. may be engaging in activities that could affect its capital structure, such as raising funds or providing incentives to investors.
  • The filing of an 8-K indicates that this is a significant event report, possibly relating to new developments, financial updates, or changes in corporate governance.
  • Investors should keep an eye on any additional disclosures that may follow this filing, particularly if it relates to the warrants which could impact share dilution or capital raising efforts.

This information is crucial for investors, analysts, and stakeholders who are assessing the company's financial health and strategic direction.